Kenneth Lippman
Rheumatology · Westport, CTNPI 1548289937
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 107 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 36.4% of the total.
Across 107 payments — averaging $46.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- GSK$247
- Mallinckrodt Hospital Products Inc.$245
- Johnson & Johnson$239
- Vanda Pharmaceuticals Inc.$233
- plus $841 from 12 others
What the payments were for
- Food & beverage$4,85598%
- Education$942%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 29 | $1,801 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 24 | $1,342 |
| GSK | 8 | $247 |
| Mallinckrodt Hospital Products Inc. | 6 | $245 |
| Johnson & Johnson | 8 | $239 |
| Vanda Pharmaceuticals Inc. | 7 | $233 |
| Neurocrine Biosciences, Inc. | 4 | $165 |
| Janssen Scientific Affairs, LLC | 1 | $125 |
| Corium, LLC | 1 | $111 |
| Supernus Pharmaceuticals, Inc. | 5 | $111 |
| UCB, Inc. | 4 | $110 |
| Teva Pharmaceuticals USA, Inc. | 3 | $68 |
| Bristol Myers Squibb | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Adlon Therapeutics L.p. | 1 | $24 |
| Almatica Pharma LLC | 1 | $22 |
| Amgen | 1 | $19 |
| Pfizer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,949 in reported general payments places this provider in the 70th percentile of 118 rheumatology providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 15 | $146 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Westport
- Kenneth MillerDanbury$873K
- Robert SchoenGuilford$638K
- Bret SohnStamford$447K
- Fotios KoumpourasNorth Haven$314K
- James SeiboldFarmington$300K
- Michael SpiegelDanbury$215K
- John MagaldiTorrington$157K
- Archana SharmaBristol$98K
- Richard RoseffDanbury$84K
- Beth ValashinasOrange$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.